| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Moderna, Inc. | Chief Commercial Officer | Restricted Stock Units | 11.4K | $1.14M | $100.01 | 05 Dec 2023 | Direct |
| Moderna, Inc. | Chief Commercial Officer | Common Stock | 3.69K | $383K | $103.90 | 06 Dec 2023 | Direct |
| Merck & Co., Inc. | SVP Human Health Global Mktg. | Common Stock | 2.11K | $252K | $119.43 | 04 May 2022 | Direct |
| Merck & Co., Inc. | SVP Human Health Global Mktg. | Restricted Stock Unit | 1.82K | $234K | $128.80 | 04 May 2022 | Direct |
| Merck & Co., Inc. | SVP Human Health Global Mktg. | Stock Option (Right to Buy) | 21.4K | 03 May 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 05 Dec 2023 | 3 | -$44.2K | 4 | Chief Commercial Officer | 07 Dec 2023, 16:21 |
| MRNA | Moderna, Inc. | 05 Sep 2023 | 3 | -$62.2K | 4 | Chief Commercial Officer | 07 Sep 2023, 16:46 |
| MRNA | Moderna, Inc. | 05 Jun 2023 | 3 | -$288K | 4 | Chief Commercial Officer | 07 Jun 2023, 16:05 |
| MRNA | Moderna, Inc. | 28 Feb 2023 | 2 | $0 | 4 | Chief Commercial Officer | 02 Mar 2023, 16:27 |
| MRNA | Moderna, Inc. | 28 Jun 2022 | 0 | $0 | 3 | Chief Commercial Officer | 29 Jun 2022, 16:04 |
| MRK | Merck & Co., Inc. | 03 May 2022 | 4 | $56.4K | 4 | SVP Human Health Global Mktg. | 05 May 2022, 17:24 |
| MRK | Merck & Co., Inc. | 03 May 2022 | 3 | $48.4K | 4 | SVP Human Health Global Mktg. | 04 May 2022, 16:44 |
| MRK | Merck & Co., Inc. | 01 May 2022 | 3 | $54.9K | 4 | SVP Human Health Global Mktg. | 03 May 2022, 16:11 |
| MRK | Merck & Co., Inc. | 28 Feb 2022 | 0 | $0 | 3 | SVP Human Health Global Mktg. | 10 Mar 2022, 18:15 |